Rodriguez-Madoz, J. R., San Jose-Eneriz, E., Rabal, O., Zapata-Linares, N., Miranda, E., Rodriguez, S., . . . Prosper, F. (2017). Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genome. PLoS One.
Dyfyniad Arddull ChicagoRodriguez-Madoz, Juan Roberto, et al. "Reversible Dual Inhibitor against G9a and DNMT1 Improves Human IPSC Derivation Enhancing MET and Facilitating Transcription Factor Engagement to the Genome." PLoS One 2017.
Dyfyniad MLARodriguez-Madoz, Juan Roberto, et al. "Reversible Dual Inhibitor against G9a and DNMT1 Improves Human IPSC Derivation Enhancing MET and Facilitating Transcription Factor Engagement to the Genome." PLoS One 2017.